Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 05985 combination versus AT1-receptor blocker/thiazide in essential hypertension
ISRCTN61335805Phase 3Completed
- Sponsor
- Servier
- Start
- Dec 2007
- Modality
- Small Molecules
01
Overview
Phase 3 trial of perindopril + indapamide + amlodipine and losartan or hydrochlorothiazide in essential hypertension (2 arms), sponsored by Servier. Primary endpoints: Overall proportion of participants with controlled blood pressure and Safety assessment. Started Dec 2007; status: completed.
02
Drugs
perindopril + indapamide + amlodipinelosartan or hydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ISRCTN61335805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61335805.